Omnaris expiration date?

When does Omnaris lose market exclusivity (expiration date)?

Omnaris (ciclesonide) expiration timing depends on which “expiration” a buyer is asking about: patent expiration, FDA exclusivity, or the end of marketing exclusivity for the reference product. Those dates often differ.

DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs, so it’s the most direct place to confirm the specific Omnaris “expiration date” that applies to your use case (e.g., generic entry timing tied to Orange Book listing and related patents). You can look up Omnaris here: https://www.drugpatentwatch.com/p/omnaris-patent-expiration/ [1]

What expiration date do people usually mean for Omnaris?

Most searches for an “Omnaris expiration date” are looking for the date when generic manufacturers can seek approval (or market) based on the last blocking patent and/or exclusivity covering the reference drug. For exact dates, you need the specific Omnaris listing (strength/formulation) and whether you’re asking about:
- patent expiration (a legal barrier), or
- exclusivity expiration (an FDA regulatory barrier).

DrugPatentWatch.com compiles those patent and exclusivity elements into a timeline you can cross-check against the Orange Book [1].

Is there a single universal date for Omnaris?

No. Omnaris can have multiple patents and exclusivities expiring on different dates, and the “effective” earliest date for generic entry can depend on which patents are still listed as blocking and whether any are challenged.

Checking the Omnaris-specific entry on DrugPatentWatch.com is the fastest way to avoid using the wrong date type (patent vs. exclusivity) [1].

Sources

[1] https://www.drugpatentwatch.com/p/omnaris-patent-expiration/